Clinical Trials Browser

OTHER_GOV × surufatinib × Thoracic × Clear all

NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma